Drs. Ibilibor and Stratton preview research from the 2022 Genitourinary Cancers Symposium.
EP. 1: 2022 ASCO GU Overview: Dr. Ibilibor on metastatic UC, RCC, and rare cancers
Christine Ibilibor, MD, discusses 6 noteworthy abstracts from the 2022 Genitourinary Cancers Symposium.
EP. 2: 2022 ASCO GU Overview: Dr. Stratton highlights top prostate cancer abstracts
Kelly L. Stratton, MD, FACS, highlights 5 pivotal prostate cancer studies from the 2022 ASCO Genitourinary Cancers Symposium.
Experts urge FDA to remove black box warning on low-dose vaginal estrogen
Phase 3 TALAPRO-2 data of talazoparib plus enzalutamide published in The Lancet
Urology in focus: Key moments from 2025
Enrollment goal met in trial of 64Cu-SAR-bisPSMA vs. 68Ga-PSMA-11 PET/CT
